Fivefa~1
Fivefa~1
Fivefa~1
Fivefa~1
Fivefa~1

Five factors to consider when scaling up biologics production to meet global commercial output

Jan. 9, 2024
Scale-up is a critical stage, with an optimized medium and robust supply chains being central to consistent product quality and a cost-effective process. Read our article to discover five key media-related factors that can help you achieve success.

Bioreactor scale-up is a critical step in the production of biologics such as therapeutic proteins, monoclonal antibodies (mAbs), and vaccines. Scaling up requires choosing the optimal media formulations, securing reliable supply chains, and maintaining product quality, all while remaining cost-effective. This article outlines five top media-related factors to consider to help you achieve success.

This content is sponsored by: